Variability of the human immunodeficiency virus type 1 polymerase gene from treatment naïve patients in Accra, Ghana

Journal of Clinical Virology

Volumn 40, Issue 2, 2007, Pages 163-167

  Sagoe, Kwamena William Coleman ^a   Dwidar, Magdar ^b   Lartey, Margaret ^a   Boamah, Isaac ^a   Agyei, Afrakoma Adjoa ^a   Hayford, Anna Aba ^a   Mingle, Julius Abraham Addo ^a   Arens, Max Q ^b  

^a UNIVERSITY OF GHANA   (Ghana)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance mutations; Ghana; HIV 1; Polymerase gene; Recombinant; Subtype; Treatment na ve

Indexed keywords

MUTANT PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS ENZYME;

ADULT; ARTICLE; GENETIC RECOMBINATION; GENETIC VARIABILITY; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR GENETICS; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS GENE; VIRUS MUTATION; VIRUS RECOMBINATION;

ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; GENES, VIRAL; GHANA; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MIDDLE AGED; MUTATION; PHYLOGENY; RANDOM ALLOCATION; VARIATION (GENETICS);

EID: 34548693401     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.07.016     Document Type: Article

References (18)

1. Agwale S.M., Zeh C., Paxinos E., Odama L., Pienazek D., Wambebe C., Kalish M.L., and Ziermann R. Genotypic and phenotypic analyses of human immunodeficiency virus type 1 in antiretroviral drug-naïve Nigerian patients. AIDS Res Hum Retrov 22 (2006) 22-26
2. Ampofo W.K., Koyanagi Y., Brandful J., Ishikawa K., and Yamamoto N. Seroreactivity clarification and viral load quantitation in HIV-1 and HIV-2 infections in Ghana. J Med Dent Sci 46 (1999) 53-62
3. Brandful J.A., Coetzer M.E., Cilliers T., Phoswa M., Papathanasopoulos M.A., Morris L., and Moore P.L. Phenotypic characterization of HIV type 1 isolates from Ghana. AIDS Res Hum Retrov 23 (2007) 144-152
4. Baxter J.D., Schapiro J.M., Boucher C.A., Kohlbrenner V.M., Hall D.B., Scherer J.R., and Mayers D.L. Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir. J Virol 80 (2006) 10794-10801
5. Carr J.K., Salminen M.O., Albert J., Sanders-Buell E., Gotte D., Birx D.L., and McCutchan F.E. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinations. Virology 247 (1998) 22-31
6. Eshleman S.H., Hackett, Swanson P., Cunningham S.P., Drews B., Brennan C., Devare S.G., Zekeng L., Kaptue L., and Marlowe N. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. Clin Microbiol 42 (2004) 2711-2717
7. Fischetti L., Opare-Sem O., Candotti D., Sarkodie F., Lee H., and Allain J.P. Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol 73 (2004) 158-166
8. Holguin A., Paxinos E., Hertogs K., Womac C., and Soriano V. Impact of frequent natural polymorphisms at the protease gene on the in-vitro susceptibility to protease inhibitors in HIV-1 non-B Subtypes. J Clin Virol 31 (2004) 215-220
9. Kinomoto M., Appiah-Opong R., Brandful J.A., Yokoyama M., Nii-Trebi N., Ugly-Kwame E., Sato H., Ofori-Adjei D., Kurata T., Barre-Sinoussi F., Sata T., and Tokunaga K. HIV-1 protease from drug-naïve West African patients are Differentially less susceptible to protease inhibitors. Clin Infect Dis 41 (2005) 243-251
10. Kim E.-Y., Winters M.A., Kagan R.M., and Merigan T.C. Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients. J Virol 75 (2001) 11227-11233
11. Lawrence P., Lutz M.F., Saoudin H., Fresard A., Cazorla C., Fascia P., Pillet S., Pozzetto B., Lucht F., and Bourlet T. Analysis of polymorphism in the protease and reverse transcriptase genes of HIV type 1 CRF02-AG subtypes from drug-naïve patients from Saint-Etienne, France. J Acq Immun Def Synd 42 (2006) 396-404
12. Montavon C., Toure-Kane C., Liegeois F., Mpoudi E., Bourgeois A., Vergne L., Perret J.L., Boumah A., Saman E., Mboup S., Delaporte E., and Peeters M. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acq Immun Def Synd 23 (2000) 363-374
13. Nadembega W.M., Giannella S., Simpore J., Ceccherini-Silberstein F., Pietra V., Bertoli A., Pignatelli S., Bellocchi M.C., Nikiema J.B., Cappelli G., Bere A., Colizzi V., Perno C.P., and Musumeci S. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. J Med Virol 78 (2006) 1385-1391
14. Simon F., Mauclere P., Roques P., Loussert-Ajaka I., Müller-Trutwin M.C., Saragosti S., Georges-Courbot M.C., Barre-Sinoussi F., and Brun-Vezinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 4 (1998) 1032-1037
15. Triques K., Bourgeois A., Vidal N., Mpoudi-Ngole E., Mulanga-Kabeya C., Nzila N., Torimiro N., Saman E., Delaporte E., and Peeters M. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retrov 16 (2000) 139-151
16. Tebit D.M., Ganame J., Sathiandee K., Nagabila Y., Coulibaly B., and Krausslich H.G. Diversity of HIV in Rural Burkina Faso. J Acq Immun Def Synd 43 (2006) 144-152
17. Vergne L., Peeters M., Mpoudi-Ngole E., Bourgeois A., Liegeois F., Toure-Kane C., Mboup S., Mulanga-Kabeya C., Saman E., Jourdan J., Reynes J., and Delaporte E. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naïve patients. J Clin Microbiol 38 (2000) 3919-3925
18. Vicente A.C., Agwale S.M., Otsuki K., Njouku O.M., Jelpe D., Idoko J.A., Caride E., Brindeiro R.M., and Tanuri A. Genetic Variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance. Virus Genes 22 (2001) 181-186